Efectos de un programa de juegos reducidos en la percepción subjetiva del esfuerzo en una muestra de chicas adolescentes

El objetivo de este trabajo fue analizar los efectos de un programa de juegos reducidos, con una duración de ocho semanas, sobre la percepción subjetiva del esfuerzo. La muestra estuvo compuesta por 42 chicasadolescentes del municipio de Priego de Córboba (Córdoba, España), con edades entre los 15 y 16 años y físicamente inactivas. Se utilizó un diseño cuasi-experimental con dos grupos aleatorizados, control y experimental. Los instrumentos utilizados fueron la Escala de Percepción Subjetiva de Esfuerzo de Borg, pulsómetros y el Game Perfomance Assessment Instrument (GPAI). Los resultados indicaron un descenso significativo en la percepción de esfuerzo e incrementos en la participación y eficacia del juego, sin existir diferencias en las frecuencias cardiacas de trabajo. Estos resultados sugierenque el aprendizaje y adaptación a los procesos de toma de decisión podrían estar en la base de este fenómeno

Effect of immunocastration on behaviour and blood parameters (cortisol and testosterone) of Holstein bulls

To evaluate the effect that immunocastration has on behaviour, testosterone and cortisol levels of feedlot Holstein bulls, 720 intact animals aged between 7 and 8 months, weighing 232±1.19 kg were randomly assigned to two treatments: immunocastration using the Bopriva vaccine and a placebo (360 animals per treatment). The bulls were slaughtered at day 239 of treatment. Animals were vaccinated on days 1, 21, 101, and 181, and on those same days testosterone levels were measured; while cortisol, glucose and creatin kinase measurements were done on day 181 and during exanguination at slaughter. Sexual, aggressive and social behaviours were evaluated and it was found that intact bulls showed a higher average of head butts, mounting, threats, flehmen sign and sniffing (P<0.05), no differences were found for vocalisations, lowering of the head and grooming (P>0.05). Testosterone levels in intact bulls remained at 0.47ng/mL throughout the study, however, by day 181 differences (P<0.05) were observed in immunised bulls, with values of 0.22ng/mL. At slaughter, testosterone levels were 0.21 ± 0.06 ng/mL in immunocastrated bulls and 0.54 ± 0.06 ng/mL in the placebo group. The use of immunocastration with Bopriva has shown to be effective to reduce testosterone, sexual and aggressive behaviours on Holstein bulls

Etnometodología para la comprensión y el manejo de la Enfermedad de Chagas en las poblaciones indígenas Wiwa asentadas en la vertiente suroriental de la Sierra Nevada de Santa Marta

El objetivo de este trabajo fue establecer prevalencia de la Enfermedad de Chagas en las comunidades Wiwa de la Sierra Nevada de Santa Marta trascendiendo el modelo de investigación biomédica sustentado en el paradigma positivista, e involucrando la dimensión sociocultural y ambiental que caracteriza este fenómeno, desde la sostenibilidad como un nuevo paradigma de las ciencias. Se realizó un muestreo probabilístico de las 15 comunidades Wiwa asentadas en la zona de San Juan del César, Departamento de la Guajira, se realizaron los procedimientos biomédicos definidos para investigaciones epidemiológicas, paralelamente se realizaron procedimientos culturales desde el saber tradicional de las comunidades Wiwa, garantizando la armonía de las comunidades ante la agresión biomédica de su espacio ambiental, social y cultural. Se obtuvo una prevalencia de 33.5%, concordante con las cifras de Enfermedad de Chagas encontradas en las otras vertientes de la sierra, reflejando condiciones similares que predisponen a la presencia de la enfermedad. Se estableció como esta enfermedad es inexistente en el sistema médico tradicional de los Wiwa, y sólo el insecto vector es reconocido aunque no considerado como agente perturbador de la salud de las comunidades. A partir de la consideración del vector como eje integrador de las dos culturas se describen las características sociales, ambientales y culturales que definen la Enfermedad de Chagas en los Wiwa y de esta forma, la posibilidad de su comprensión y manejo desde factores complementarios al modelo biomédico.The goal of this research was to establish Chagas Disease prevalence in Wiwa communities of Sierra Nevada de Santa Marta, beyond biomedical research model supported in positivist paradigm, towards sustainability as a new paradigm of science, by which this phenomenon has a social, cultural and environmental dimensions. A probabilistic sample was made it in 15 Wiwa communities placed in San Juan del Cesar area, La Guajira. Biomedical procedures defined from epidemiological research were made them, and simultaneously, cultural procedures derived from ancestral knowledge of Wiwa communities were made them, guarantee harmony in communities against biomedical aggression of environmental, cultural and social dimensions. A 33.5% prevalence of Chagas Disease was obtained, similar to prevalence reported in other sierra's slope with similar conditions related to disease transmission. It was established that chagas disease doesn't exist in Wiwa traditional medical system, and only vector insect is recognized but not considered as a disturbed agent of communities' health. Social, environmental and cultural characteristics that define Chagas disease were described since consideration that vector insect is an integrating axis of two cultures, and in this way, possibilities to comprehension and management of chagas disease, complementing biomedical model, were described too

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

© The Author(s) 2018.Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using next-generation flow cytometry (NGF) and correlated our findings with the distinct diagnostic and prognostic categories of the disease. Overall, 508 samples from 264 newly diagnosed PCN patients, were studied. CTPC were detected in PB of all active multiple myeloma (MM; 100%), and smoldering MM (SMM) patients (100%), and in more than half (59%) monoclonal gammopathy of undetermined significance (MGUS) cases (p <0.0001); in contrast, CTPC were present in a small fraction of solitary plasmacytoma patients (18%). Higher numbers of CTPC in PB were associated with higher levels of BM infiltration and more adverse prognostic features, together with shorter time to progression from MGUS to MM (p <0.0001) and a shorter survival in MM patients with active disease requiring treatment (p ≤ 0.03). In summary, the presence of CTPC in PB as assessed by NGF at diagnosis, emerges as a hallmark of disseminated PCN, higher numbers of PB CTPC being strongly associated with a malignant disease behavior and a poorer outcome of both MGUS and MM.This work has been supported by the International Myeloma Foundation-Black Swan Research Initiative and the EuroFlow Consortium; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC; Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Madrid, Spain and FONDOS FEDER), numbers: CB16/12/00400, CB16/12/00369, CB16/12/00489 and CB16/12/00233; grant SA079U14 from the Consejería de Educación, Junta de Castilla y León, Valladolid, Spain and; grant DTS15/00119 from Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Madrid, Spain. Acuerdo de colaboración con Fundación de Hemoterapia y Hemodonación de Castilla y León, Valladolid, Spain. This study was also supported by the Qatar National Research Fund (QNRF) Award No. 7-916-3-237, the AACR-Millennium Fellowship in Multiple Myeloma Research (15-40-38-PAIV), ERA-NET TRANSCAN-2 (iMMunocell), by a 2017 Leonardo Grant (BZG10931) for Researchers and Cultural Creators, BBVA Foundation, and the European Research Council (ERC) 2015 Starting Grant (MYELOMANEXT)

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using next-generation flow cytometry (NGF) and correlated our findings with the distinct diagnostic and prognostic categories of the disease. Overall, 508 samples from 264 newly diagnosed PCN patients, were studied. CTPC were detected in PB of all active multiple myeloma (MM; 100%), and smoldering MM (SMM) patients (100%), and in more than half (59%) monoclonal gammopathy of undetermined significance (MGUS) cases (p < 0.0001); in contrast, CTPC were present in a small fraction of solitary plasmacytoma patients (18%). Higher numbers of CTPC in PB were associated with higher levels of BM infiltration and more adverse prognostic features, together with shorter time to progression from MGUS to MM (p < 0.0001) and a shorter survival in MM patients with active disease requiring treatment (p <= 0.03). In summary, the presence of CTPC in PB as assessed by NGF at diagnosis, emerges as a hallmark of disseminated PCN, higher numbers of PB CTPC being strongly associated with a malignant disease behavior and a poorer outcome of both MGUS and MM

Comparación de la castración quirúrgica al nacimiento versus inmunocastration sobre las características de la canal y carne en machos Holstein

El objetivo fue comparar el efecto de la castración quirúrgica al nacimiento vs immunocastración, sobre las características de la canal y carne en machos Holstein en engorda; se utilizaron 720 machos Holstein aproximadamente de 7 a 8 meses de edad con peso inicial de 240.82 kg. Se formaron 2 tratamientos con 4 corrales de 90 animales en cada uno: toros castrados quirúrgicamente que fueron castrados 24 h después del nacimiento y toros inmunocastrados vacunados con Bopriva aplicando cuatro dosis, al día 1, 21, 101 y 181 de engorda. Se tomaron pesos individuales en cada vacunación. Los animales se sacrificaron a los 242 días de engorda. A partir de la segunda vacunación se observaron diferencias (P0.05) entre tratamientos mientras que los valores de b*, C* y H* fueron más altos (P<0.05) en los animales inmunocastrados. Para fines de producción, el sacrificar los machos Holstein al nacimiento, se obtienen animales más pesados y con mejores características en la canal; sin embargo es importante evaluar el impacto del bienestar animal por la castración al nacimiento

Results of an early access treatment protocol of daratumumab monotherapy in spanish patients with relapsed or refractory multiple myeloma

Daratumumab is a human CD38-targeted monoclonal antibody approved as monotherapy for heavily pretreated relapsed and refractory multiple myeloma. We report findings for the Spanish cohort of an open-label treatment protocol that provided early access to daratumumab monotherapy and collected safety and patient-reported outcomes data for patients with relapsed or refractory multiple myeloma. At 15 centers across Spain, intravenous daratumumab (16mg/kg) was administered to 73 patients who had ≥3 prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug, or who were double refractory to both. The median duration of daratumumab treatment was 3.3 (range: 0.03–13.17) months, with a median number of 12 (range: 1–25) infusions. Grade 3/4 treatment-emergent adverse events were reported in 74% of patients and included lymphopenia (28.8%), thrombocytopenia (27.4%), neutropenia (21.9%), leukopenia (19.2%), and anemia (15.1%). Common (>5%) serious treatmentemergent adverse events included respiratory tract infection (9.6%), general physical health deterioration (6.8%), and back pain (5.5%). Infusion-related reactions occurred in 45% of patients. The median change from baseline in all domains of the EQ-5D-5L and EORTC QLQ-C30 was mostly 0. A total of 18 (24.7%) patients achieved a partial response or better, with 10 (13.7%) patients achieving a very good partial response or better. Median progression-free survival was 3.98 months. The results of this early access treatment protocol are consistent with previously reported trials of daratumumab monotherapy and confirm its safety and antitumoral efficacy in Spanish patients with heavily treated relapsed or refractory multiple myeloma

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using next-generation flow cytometry (NGF) and correlated our findings with the distinct diagnostic and prognostic categories of the disease. Overall, 508 samples from 264 newly diagnosed PCN patients, were studied. CTPC were detected in PB of all active multiple myeloma (MM; 100%), and smoldering MM (SMM) patients (100%), and in more than half (59%) monoclonal gammopathy of undetermined significance (MGUS) cases (p < 0.0001); in contrast, CTPC were present in a small fraction of solitary plasmacytoma patients (18%). Higher numbers of CTPC in PB were associated with higher levels of BM infiltration and more adverse prognostic features, together with shorter time to progression from MGUS to MM (p < 0.0001) and a shorter survival in MM patients with active disease requiring treatment (p <= 0.03). In summary, the presence of CTPC in PB as assessed by NGF at diagnosis, emerges as a hallmark of disseminated PCN, higher numbers of PB CTPC being strongly associated with a malignant disease behavior and a poorer outcome of both MGUS and MM

Volviéndonos mejores: necesidad de acción inmediata ante el reto de la obesidad. Una postura de profesionales de la salud.

La creciente epidemia de obesidad ha sido uno de los retos más importantes de salud pública en México durante los últimos años. Con apoyo de la Federación Mundial de Obesidad, en 2021 formamos un grupo de profesionales para identificar y resumir las acciones prioritarias en las que puede enfocarse nuestro país para hacer frente a esta epidemia. Al proceso de desarrollo y discusión de este grupo se sumaron más de 1 000 profesionales de la salud para retomar recomendaciones de documentos y guías de alto nivel previamente publicados. En conmemoración del Día Mundial de la Obesidad, en este 2022 se presenta esta postura como insumo para el desarrollo de acciones en el ámbito profesional y de los diferentes sectores, en la que se incluyen 10 recomendaciones de acción, desde la perspectiva poblacional hasta la atención individualizada, y se enfatiza en la importancia de la participación social, de las intervenciones integrales con visión centrada en la persona y de la sostenibilidad planetaria, además de mejorar la educación y las campañas de difusión, propiciar un ambiente promotor de entornos activos y blindar de conflictos de interés los esfuerzos de prevención y control. La postura hace un llamado para abordar la obesidad de manera seria, con base en la evidencia científica, oportuna e integral, con enfoque de curso de vida, de forma ética y sensible, y sin perpetuar las barreras del estigma de peso en la sociedad